about bpc 157 BPC-157 Therapy in Austin Christopher Mendias, PhD, gets four

FDA Approval Status: The Unapproved Drug Classification Is BPC-157 FDA-approved for human use

Preclinical Evidence Across Tissue Types Soft Tissue (Muscle, Tendon, and Ligament) Models: Many rodent studies have examined BPC-157 in models of musculoskeletal injury: In rat tendon and ligament injury experiments, administration of BPC-157 accelerated collagen organization and improved measures of biomechanical integrity relative to untreated controls (4)

Pick your vial size Most lyophilised research peptides ship as 2, 5, 10, or 15 mg vials

The SURMOUNT-1 trial demonstrated up to 22.5% body weight reduction with tirzepatide at the highest dose (15mg weekly), compared to semaglutide's 14.9% in STEP 1